Shipping list no.: 2007-0317-P. ; Distributed to some depository libraries in microfiche. ; Includes bibliographical references. ; Mode of access: Internet.
Shipping list no.: 2003-0081-P. ; Distributed to some depository libraries in microfiche. ; "Printed for the use of the Committee on Foreign Relations." ; Includes bibliographical references. ; Mode of access: Internet.
A study of the involvement of organized-crime and terrorist groups in product counterfeiting. Case studies of film piracy illustrate the problem of criminal-and perhaps terrorist-groups using this new high-payoff, low-risk way to fund their activities. Cooperation among law enforcement and governments worldwide is needed to combat intellectual-property theft, which threatens the global information economy, public safety, and national security
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Counterfeit and pirated products come from many economies, with China appearing as the single largest producing market. These illegal products are frequently found in a range of industries, from luxury items (e.g. fashion apparel or deluxe watches), via intermediary products (such as machines, spare parts or chemicals) to consumer goods that have an impact on personal health and safety (such as pharmaceuticals, food and drink, medical equipment, or toys). This report assess the quantitative value, scope and trends of this illegal trade
The counterfeiting of medicinal products is a growing concern for patients, the pharmaceutical industry and national policy-makers worldwide. EU internal market rules for medicinal products for human use coupled by wide-ranging International cooperation, and proposed European legislative reforms are hoped to have a positive impact against the problem of counterfeit medicines - one of the greatest current threats to public health and safety. ; peer-reviewed
"Serial no. 109-194." ; Shipping list no.: 2007-0134-P. ; Distributed to some depository libraries in microfiche. ; Includes bibliographical references. ; Mode of access: Internet.
"Offering a considered analysis of pharmaceutical rights and wrongs as they have developed over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health advocates." -- dust jacket
"Serial no. 109-88." ; Shipping list no.: 2006-0203-P. ; Distributed to some depository libraries in microfiche. ; Includes bibliographical references. ; Mode of access: Internet.
Acknowledgements -- Introduction -- South America -- Bargaining and selling : regimes of value in a market before the war against piracy -- Traveling and smuggling : intellectual property discourse reaches Brazil -- Migrating and importing : Chinese community in a time of change -- China -- Enterprising and producing: leisure and sacrifice in the production system -- Protecting and dreaming : state interests, elite alliances, and laissez-faire -- Ending and changing routes -- Index.
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Distributed to some depository libraries in microfiche. ; Shipping list no.: 2007-0024-P. ; Includes bibliographical references. ; Mode of access: Internet.
Shipping list no.: 2006-0118-P. ; Distributed to some depository libraries in microfiche. ; "Printed for the use of the Committee on Homeland Security and Governmental Affairs." ; Includes bibliographical references. ; Mode of access: Internet.
Counterfeiting of medicines constitutes as a threat to public health, which nowadays has a "pandemic character". In this regard, the legislation of the Republic of Belarus should properly address the risks caused by counterfeited medicines. Being a member of several economic alliances aimed at simplifying turnover of goods, including medical products, Belarus needs to develop comprehensive preventive measures and provide effective and proportionate criminal and other sanctions for the commission of acts connected with counterfeiting of medicines. This article focuses on key factors which impact the development of Belorussian legislation. The main obstacles for effective international cooperation in criminal matters concerning turnover of counterfeit medicines are also explored. Amendments to legislation aimed at improving the effectiveness of combating counterfeiting of medicines will also be discussed.